Trial Profile
Drug Use Investigation of EOB-Primovist Inj. Syringe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2017
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Registrational
- Sponsors Bayer
- 21 Mar 2017 New trial record